[Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003238:Connective Tissue / Q000187:drug effects; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use; D006168:Guinea Pigs; D007538:Isoniazid / Q000494:pharmacology / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D008221:Lymphoid Tissue / Q000187:drug effects; D009163:Mycobacterium bovis / Q000187:drug effects*; D011718:Pyrazinamide / Q000627:therapeutic use; D011817:Rabbits; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
Eksperimental'noe izuchenie tuberkulostaticheskikh preparatov vtorogo riada pri ustoĭchivosti mikobakteriĭ k osnovnym preparatam.